Drug of choice for social phobia is
Social phobia, also known as social anxiety disorder, is typically treated with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These are first-line medications because they target the serotonin system, which is involved in regulating anxiety and mood. Benzodiazepines might be used for acute situations but aren't first-line due to the risk of dependence. Beta-blockers like propranolol are used for physical symptoms, such as during public speaking, but not as primary treatment. Tricyclic antidepressants (TCAs) are sometimes used but less preferred due to side effects.
The correct answer here would be an SSRI or SNRI. Common examples include paroxetine, sertraline, or venlafaxine. Now, looking at the options provided, the correct answer is likely one of these. The wrong options might include benzodiazepines, beta-blockers, or TCAs. Each of these alternatives has their own rationale for not being the first choice. For example, benzodiazepines can be effective but have abuse potential, while beta-blockers only address physical symptoms without tackling the psychological aspect. TCAs are effective but have more side effects like anticholinergic effects.
So, putting this together, the drug of choice is an SSRI or SNRI. The clinical pearl here is that SSRIs/SNRIs are first-line for social phobia, and benzodiazepines are not recommended as primary treatment. Also, beta-blockers are adjuncts for specific situations. The correct answer would be an SSRI like paroxetine or sertraline. Each incorrect option's reasoning should be explained clearly.
**Core Concept**
Social phobia (social anxiety disorder) is primarily managed with **selective serotonin reuptake inhibitors (SSRIs)** or **serotonin-norepinephrine reuptake inhibitors (SNRIs)**. These agents modulate serotonin and norepinephrine pathways, reducing anxiety symptoms through long-term neurochemical adaptation.
**Why the Correct Answer is Right**
The correct answer is **paroxetine (SSRI)** or **venlafaxine (SNRI)**, which are first-line pharmacologic treatments. SSRIs/SNRIs enhance serotonin (and norepinephrine in SNRIs) activity in the prefrontal cortex and limbic system, dampening hyperactivation of the amygdala during social stressors. Paroxetine, specifically, is FDA-approved for social anxiety disorder and demonstrates efficacy in reducing both cognitive and physical symptoms.
**Why Each Wrong Option is Incorrect**
**Option A:** *Benzodiazepines (e.g., alprazolam)* are not first-line due to risks of tolerance, dependence, and cognitive impairment.
**Option B:** *Beta-blockers (e.g., propranolol)* may reduce physical symptoms (tremors, tachycardia) in specific situations (e.g., public speaking) but do not address the core psychological components.
**Option C:** *Tricyclic